The oil and gas industry will spend just under $10 billion in 2014 for valves. This is the conclusion reached by the McIlvaine Company in Industrial Valves: World Markets.  (www.mcilvainecompany.com)

* The largest purchases will be ball valves which will account for 30 percent of the total. Gate valves will account for $1.8 billion of the revenues. One major use of gate valves is at the wellhead in an assembly known as the "Christmas Tree." Valve functions include directing oil and gas from the well to further processing, shutting down the well, and injection of various chemicals for well stimulation or enhanced oil recovery.  Check valves are also used for this service.

Pipeline applications include periodically spaced isolation valves for segmenting the pipeline in the event of a leak or the need for other service. These valves are typically full-ported gate or ball valves which provide low pressure drop when fully open, tight shutoff when closed and full porting to permit pipeline pigging.

The total investment for a 200 mcfd gas processing plant would be $150 million and would require an expenditure of $5 million for valves. Twenty percent would be for control and 80 percent would be on/off.

An LNG liquefaction plant can cost $8.3 billion. The valve portion would be 1 percent or $83 million. There are a number of liquefaction projects underway in the U.S. due to the abundance of shale gas.

For more information on Industrial Valves: World Markets, click on:
http://home.mcilvainecompany.com/index.php?option=com_content&view=article&id=71#n028.

China enjoys the fastest growing cleanroom industry in the world.  Domestic purchases are growing at double-digit rates and the exports are growing even faster.  Operators will be spending more than $300 million/yr for hardware by 2016.

 Chinese consumables sales are also growing at double-digit rates and will exceed $490 million in 2016.

The pharmaceutical industry has the highest growth percentage even though the total purchases are less than the semiconductor industry.  China accounts for 20 percent of the world’s population but only 1.5 percent of the global drug market. However, this market is growing at more than 20%/yr and is expected to exceed $115 billion in 2015.  Many new cleanrooms are under construction. The large international pharmaceutical manufacturers are building plants to supply the domestic and export markets. One strategy is for brand name companies to compete in generics by manufacturing these generic products in China. There are large numbers of cleanrooms in planning and construction to house research efforts of international companies.

For more information on World Cleanroom Markets, click on: http://home.mcilvainecompany.com/index.php?option=com_content&view=article&id=73